home / stock / dmt:cc / dmt:cc news

DMT:CC News and Press, Small Pharma Inc. From 07/26/22

Stock Information
Company Name: Small Pharma Inc.
Stock Symbol: DMT:CC
Market: TSXVC
Website: smallpharma.com
Menu
DMT:CC DMT:CC Quote DMT:CC Short DMT:CC News DMT:CC Articles DMT:CC Message Board
Get DMT:CC Alerts

News, Short Squeeze, Breakout and More Instantly...
DMT:CC - U.S. Patent Grant to Strengthen Small Pharma's DMT Patent Strategy With Injectable Formulation

Key U.S. patent protection on injectable delivery of DMT in lead programs SPL026 and SPL028 LONDON, July 26, 2022 (GLOBE NEWSWIRE) -- Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (the “ Company ” or “ Small Pharma ”), a biotechnology company...
DMT:CC - George Tziras to Succeed Peter Rands as Small Pharma Chief Executive Officer

Building on strong foundations to take Small Pharma through development to commercial success Peter Rands to take on role as Chief Innovation & Intellectual Property Officer LONDON, July 18, 2022 (GLOBE NEWSWIRE) -- Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) ...

DMT:CC - Small Pharma Reports Fiscal First Quarter 2023 Highlights

Progress continues apace with multiple trials expected to enter clinic later this year First US patent granted LONDON, July 15, 2022 (GLOBE NEWSWIRE) -- Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (the “ Company ” or “ Small Phar...

DMT:CC - Small Pharma to Participate in the H.C. Wainwright 1st Annual Mental Health Conference on June 27, 2022

LONDON, United Kingdom, June 22, 2022 (GLOBE NEWSWIRE) -- Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (the “ Company ” or “ Small Pharma ”), a biotechnology company focused on short-acting psychedelic-assisted therapies for mental health conditions, anno...
DMT:CC - Small Pharma Reports Highlights for the Fiscal Year Ended February 28, 2022

Reporting its financial results and continued p rogress across short-acting psychedelics portfolio Executive team and IP position strengthened LONDON, June 09, 2022 (GLOBE NEWSWIRE) -- Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (the “ Com...

DMT:CC - Small Pharma To Present at the Jefferies Healthcare Conference in New York City on June 10, 2022

LONDON, May 30, 2022 (GLOBE NEWSWIRE) -- Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (the “ Company ” or “ Small Pharma ”), a biotechnology company focused on short-acting psychedelic-assisted therapies for mental health conditions, announces that P...

DMT:CC - Small Pharma Shares Business Update Ahead of Annual Financial Results

- Appointment of Alastair Riddell as COO - Two new Composition of Matter patents granted for pipeline projects - Progress continues across short-acting psychedelics portfolio LONDON, May 25, 2022 (GLOBE NEWSWIRE) -- Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (the ...
DMT:CC - Small Pharma to Participate in the PSYCH Symposium: London 2022

LONDON, May 05, 2022 (GLOBE NEWSWIRE) -- Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (the “ Company ” or “ Small Pharma ”), a biotechnology company focused on short-acting psychedelic-assisted therapies for mental health conditions, will participate in t...

DMT:CC - New Stocks and Trading Ideas

Vancouver, Kelowna, Delta, BC - April 28, 2022 (Investorideas.com Newswire) Investorideas.com , a global news source and expert investing resource, announces its weekly roundup of stocks to watch in Biotech, Mining and Cleantech. Today's stocks have been added to our lists of free stock...

DMT:CC - KCSA Psychedelics Virtual Investor Conference Presentations Now Available for On-Demand Viewing

NEW YORK, April 29, 2022 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced that the presentations from the April 27 th and 28 th KCSA Psychedelics Virtual Investor Conference are now available for on-demand viewing....
Previous 10 Next 10